SYK
Stryker Corporation · Healthcare · Medical - Devices
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 438.61K | $109.42M | n/a | −3 |
| Q2 2026 | 170 | +2 | 220.81M | $69.86B | +7 | −6 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | n/a | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | n/a |
| Q2 2024 | 16 | n/a | 41.27M | $14.03B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 11.70M | n/a | $3.98B | 0.5% | n/c | 1 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 11.24M | n/a | $3.82B | 0.7% | n/c | 1 | SEC ↗ ×8 |
| 3 | Geode Capital Management ✦ (pasivo) | 6.74M | n/a | $2.29B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 5.00M | n/a | $1.70B | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 4.28M | n/a | $1.46B | 0.6% | n/c | 1 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 447.50K | n/a | $152.26M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 375.30K | n/a | $127.70M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 325.20K | n/a | $110.65M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 324.94K | n/a | $110.56M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 306.80K | n/a | $104.39M | 0.5% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 232.64K | n/a | $79.16M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 125.33K | n/a | $42.49M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 13 | Marshall Wace ✦ | 122.20K | n/a | $41.58M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 14 | Millennium Management ✦ | 33.32K | n/a | $11.34M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 14.19K | n/a | $4.83M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 1.25K | n/a | $424,632 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 2,274 tenedores, 283.44M acciones, $87.41B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Director · 18 acc. @ 225.19 · $4,054
Director · 3 acc. @ 185.65 · $557
Director · 36 acc. @ 193.21 · $6,956
Director · 11 acc. @ 221.03 · $2,431
Director · 63 acc. @ 202.21 · $12,739
Ventas en mercado abierto (S)
Officer · 441 acc. · $144,915
Director · 11.26K acc. · $3.81M
Director · 40 acc. · $13,272
Director · 440 acc. · $146,598
Director · 200 acc. · $66,786
Director · 80 acc. · $26,804
Director · 320 acc. · $107,774
Director · 2.31K acc. · $780,062
Director · 10.81K acc. · $3.67M
Director · 16.61K acc. · $5.66M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología